Trump’s Surprise Women’s Health Power Play

President Trump signed an order creating a new Women’s Health Division at the National Institutes of Health and a White House task force, signaling a rare bipartisan-style push to fix long-ignored gaps in women’s care.

Story Highlights

Trump established a Women’s Health Division at the National Institutes of Health and a White House Women’s Health Task Force.
The order targets diseases that affect women and have been understudied, including endometriosis and menopause-related issues.
Melania Trump helped drive the plan and outlined five policy pillars, including research funding and faster treatments.
No funding totals were disclosed; the new division will not replace the current Office of Research on Women’s Health.

What the Executive Order Does

President Trump signed an executive order that creates a Women’s Health Division at the National Institutes of Health and a White House Women’s Health Task Force. The White House described a “comprehensive approach to women’s health” across the life course. The plan names conditions such as Alzheimer’s disease, endometriosis, infertility, maternal health, and menopause. The move highlights a federal focus on illnesses that affect women and have received less attention in studies and treatment pipelines.

Reports state the new division adds to, and does not replace, the existing Office of Research on Women’s Health at the National Institutes of Health. Officials framed the change as broader than research alone, with goals that include speeding up development of treatments and improving access. The administration did not release specific funding amounts tied to the order. That leaves budget scale and pace of implementation to be detailed by agencies in the coming period.

How the First Lady Shaped the Plan

First Lady Melania Trump played a central role in shaping the initiative, according to statements shared with reporters. She said she organized working sessions with physicians, East Wing policy staff, President Trump, Health and Human Services leadership, and other stakeholders to form the order. Her five policy pillars include stronger research funding, use of artificial intelligence, faster access to treatments, affordability, and breaking silence around women’s health topics that many families still find hard to discuss openly.

This public push pairs with a larger pattern in health policy. For decades, experts have argued that women’s health research receives a smaller share of attention and money than its burden warrants. A National Academies analysis found women’s health research averaged 8.8 percent of National Institutes of Health spending from 2013 to 2023, and fell to 7.9 percent in 2023. Advocates say leadership authority and funding power determine whether new structures drive real change.

Why It Matters to Families and Taxpayers

Women and families face costs from late diagnoses, limited treatments, and poor coverage for conditions that affect daily life and work. If the new division elevates research and speeds therapies, households could see clearer guidance and better options. If agencies also focus on affordability, patients could face fewer trade-offs between care and monthly bills. The task force’s success will hinge on agency coordination, timely milestones, and whether Congress and the administration back goals with resources.

Trump and the First Lady are set to sign an order creating an NIH Women's Health Division as the Supreme Court takes up the federal ban on home distilling.

• Executive order creates an NIH Women's Health Division and a White House task force led by Susie Wiles and RFK Jr.,…

— Ping AI (@TextPingAI) October 19, 2026

Americans across the political spectrum share a view that Washington often talks big and delivers slow. This initiative will be judged on execution. Clear targets, transparent budgets, and regular progress reports can show whether the new division and the task force cut red tape and help patients faster. Officials also say the existing office remains in place, which can reduce confusion if roles are defined well and if both groups align toward measurable results the public can track.